NEWSROOM

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

read more
SKYX to Participate in the 36th Annual ROTH Conference

SKYX to Participate in the 36th Annual ROTH Conference

MIAMI, FL, March 18, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. Founder and...

read more
Auto Parts 4 Less Group Inc. Continues to Strengthen Balance Sheet with Additional Debt Conversion

Auto Parts 4 Less Group Inc. Continues to Strengthen Balance Sheet with Additional Debt Conversion

Las Vegas, NV, March 18, 2024 - PRISM MediaWire - Auto Parts 4 Less Group, Inc. (OTC: FLES) (“Auto Parts4Less,” “the Company”), a technology-driven e-commerce leader in the automotive parts sector, is pleased to announce another significant step in its ongoing efforts to improve its financial position. The Company has successfully converted $461,450k of debt into common stock, with a two-year lockup period, further demonstrating its commitment to cleaning up its balance sheet and moving...

read more
BranchOut Food to Debut New Products at Natural Products Expo West

BranchOut Food to Debut New Products at Natural Products Expo West

Natural Products Expo West showcases trending products for retailers stocking stores shelves nationwide BranchOut Food will launch two new products lines including Salad Toppers and Kids’ Snack Packs BEND, Ore., March 13, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it will debut a brand refresh and launch two new product lines at its exhibit at the Natural Products Expo West,...

read more
brooqLy Announces Launch of Operations in Czech Republic

brooqLy Announces Launch of Operations in Czech Republic

Palos Hills, IL, March 13, 2024—brooqLy, Inc. (OTC: BRQL), a technology company, today announced the launch of its operations in the Czech market. This expansion marks a milestone in brooqLy's strategic growth plan, potentially strengthening its presence in Central Eastern and South Eastern Europe. This move also represents the first of three new planned markets for brooqLy in 2024. The anticipated launch of operations in the Czech Republic is slated for the early summer of 2024 and the...

read more
SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India FORT LAUDERDALE, FL, March 12, 2024 - SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII) ), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons...

read more
Auto Parts 4 Less Group Inc. Continues to Strengthen Balance Sheet with Additional Debt Conversion

Auto Parts 4 Less Group Inc. Announces Successful Debt Conversion to Strengthen Balance Sheet

Las Vegas, NV, March 11, 2024 - Auto Parts 4 Less Group, Inc. (OTC Pink: FLES) (the “Company,” “Auto Parts4Less,” “FLES”), a technology-driven e-commerce leader in the automotive parts sector, is pleased to announce a significant milestone in its ongoing efforts to improve its financial position. On March 6th and 8th, 2024, the Company successfully converted debt and accounts payable totaling $1,195,506 into common stock, with a two-year lockup period. "This debt conversion is a testament to...

read more
EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

TULSA, Okla., March 7, 2024 - Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has commenced its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $25.0 million. The Company is distributing at no charge to holders of its...

read more
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

New York, N.Y., March 07, 2024 - PRISM MarketView announces the release of an insightful interview with Lipella Pharmaceuticals’ CEO, Dr. Jonathan Kaufman, discussing the company's recent regulatory accomplishments and how investors stand to benefit. Lipella Pharmaceuticals was recently granted Orphan Drug Designation by the FDA for LP-410, its drug candidate for oral Graft-versus-Host Disease (GvHD) and previously received Orphan Drug Designation for LP-10 in 2023. With these nods from the...

read more
Premier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)

Premier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)

Mr. Carreño’s experience and connections in Mexico furnishes Premier with unique advantages for closing its pending transactions Imperial Valley, CA, March 7, 2024 - Premier Graphene Inc. (OTC: BIEI) proudly announces the appointment of visionary industry leader, Gustavo Carreño, as its new Chief Technology Officer (CTO). Mr. Carreño is poised to steer the Company into a future defined by groundbreaking innovation and transformative growth. With a proven track record at the forefront of...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850